Biotech startup AmplifyBio lands $50M non-dilutive debt financing … – The Business Journals
Battelle regenerative medicine spinoff AmplifyBio LLC has landed up to $50 million in debt financing from a Silicon Valley “venture lending” firm, which will help the contract research organization speed facilities expansion and technology development. Hercules Capital Inc. (NYSE: HTGC), based in Palo Alto, has provided non-dilutive loans to national brands such as Carbon Health, … Read more